This poster set includes water, sanitation and hygiene (WASH) posters to teach about good WASH practices, including household water treatment technologies. The poster set also includes text for each poster with key messages and questions to check for understanding with the group or individual.
This poster set includes water, sanitation and hygiene (WASH) posters to teach about good WASH practices, including household water treatment technologies.
This poster set includes water, sanitation and hygiene (WASH) posters to teach about good WASH practices, including household water treatment technologies.
Eine gemeinsame Arbeitsgruppe der Stadt Münster und der Ärztekammer Westfalen-Lippe hat mit der folgenden Broschüre versucht, wichtige Informationen zur Bedeutung und zu den Anforderungen an ein ärztliches Attest im Vollstreckungsverfahren nach Ablehnung eines Asylbegehrens zusammenzustellen. Si...e soll behördlich beauftragten oder initiativ angefragten Ärztinnen und Ärzten als unterstützende und pragmatische Hilfe bei der Beurteilung der Reisefähigkeit ausreisepflichtiger Personen dienen.
more
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been... updated to reflect the wealth of practical
experience in conducting medicine prices and availability surveys garnered in the project’s first two phases.
more
This fact sheet developed by CAWST describes the history of soap, how it’s made, and the two processes for making soap. This fact sheet is available in English, Spanish, and French.
Over 3000 resources to use with your projects, training, and community education in different languages
Empfehlungen f ür das politische Handeln des Bundes und der Länder so wie angeschlossene Behörden
Version 01, veröffentlichtam 16.12.2020
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatment of chronic noncommunicable diseases. The evaluation combines both quantitative and qualitative anal...ysis. The findings confirm that the Programme has contributed to a significant increase in access to needed outpatient medicines in Ukraine. Further, while implementation was successful overall, uptake across regions was uneven. The report concludes by listing a number of policy options to support the sustainability and expansion of the Affordable Medicines Programme.
more
On April 1, 2017, the Ukrainian government launched the Affordable Medicines National Prescription Drugs Cost Reimbursement Program providing for full or partial reimbursement of essential medicines for treatment of cardiovascular diseases, asthma and diabetes mellitus type 2 (also known as type 2 d...iabetes).
more
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
Heart failure (HF) is a leading global public health problem with >64 million prevalent cases globally. Patients with HF with reduced ejection fraction (HFrEF) from low- and middle-income countries experience a 22% to 58% higher 1-year mortality rate than those in high-income countries.1 Guideline-d...irected medical therapy (GDMT) consisting of ACE (angiotensin-converting enzyme) inhibitors or ARB (angiotensin receptor blockers) or ARNI (angiotensin receptor-neprilysin inhibitors), β-blockers, MRA (mineralocorticoid receptor antagonists), and SGLT2 (sodium-glucose cotransporter 2) inhibitors substantially reduces mortality among patients with HFrEF. These medicines are among the most cost-effective interventions and are thus included as the highest priority health system interventions recommended by the Disease Control Priorities Project.2 Despite this high-quality evidence, GDMT remains widely underutilized in low- and middle-income countries resulting in widespread undertreatment of patients with HFrEF due to health system-, provider-, and patient-level barriers.1 National essential medicines lists (EMLs) promoted by the World Health Organization (WHO) guide countries on which medications to purchase in the setting of limited resources and have resulted in higher procurement and availability of essential medicines in the public sector.3 We provide a cross-sectional analysis of national EMLs in 53 low- and middle-income countries, and availability, price, and affordability of GDMT in select countries to identify potential barriers to access to these essential medicines for patients with HFrEF.
more